Login / Signup

Genetic modifiers of synucleinopathies-lessons from experimental models.

Rachel Min Qi LeeTong-Wey Koh
Published in: Oxford open neuroscience (2023)
α-Synuclein is a pleiotropic protein underlying a group of progressive neurodegenerative diseases, including Parkinson's disease and dementia with Lewy bodies. Together, these are known as synucleinopathies. Like all neurological diseases, understanding of disease mechanisms is hampered by the lack of access to biopsy tissues, precluding a real-time view of disease progression in the human body. This has driven researchers to devise various experimental models ranging from yeast to flies to human brain organoids, aiming to recapitulate aspects of synucleinopathies. Studies of these models have uncovered numerous genetic modifiers of α-synuclein, most of which are evolutionarily conserved. This review discusses what we have learned about disease mechanisms from these modifiers, and ways in which the study of modifiers have supported ongoing efforts to engineer disease-modifying interventions for synucleinopathies.
Keyphrases
  • endothelial cells
  • multiple sclerosis
  • transcription factor
  • copy number
  • physical activity
  • small molecule
  • quality improvement
  • ultrasound guided
  • cell wall
  • fine needle aspiration